Literature DB >> 14722198

Hepatic manifestations of autoimmune rheumatic diseases.

S Abraham1, S Begum, D Isenberg.   

Abstract

Hepatic manifestations in autoimmune disease include chronic active hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, and nodular regenerative hyperplasia. These diseases are rare and may occur concomitantly or serially. Clinicians must be aware of the possibility of liver disease so that it can be treated as soon as possible.

Entities:  

Mesh：

Year:  2004        PMID： 14722198      PMCID： PMC1754901          DOI： 10.1136/ard.2002.001826

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  66 in total

1.  CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES.

Authors:  E L DUBOIS; D L TUFFANELLI
Journal:  JAMA       Date:  1964-10-12       Impact factor: 56.272

2.  Apparent hepatic dysfunction in lupus erythematosus.

Authors:  S KOFMAN; G C JOHNSON; H J ZIMMERMAN
Journal:  AMA Arch Intern Med       Date:  1955-05

3.  Sclerosing cholangitis: its possible association with Riedel's struma and fibrous retroperitonitis. Report of two cases.

Authors:  L G BARTHOLOMEW; J C CAIN; L B WOOLNER; D C UTZ; D O FERRIS
Journal:  N Engl J Med       Date:  1963-07-04       Impact factor: 91.245

4.  Systemic scleroderma, A clinical study of 727 cases.

Authors:  D L TUFFANELLI; R K WINKELMANN
Journal:  Arch Dermatol       Date:  1961-09

5.  Budd-Chiari syndrome and the lupus anticoagulant.

Authors:  F Roudot-Thoraval; M Gouault-Heilmann; E S Zafrani; J Barge; D Dhumeaux
Journal:  Gastroenterology       Date:  1985-02       Impact factor: 22.682

Review 6.  Cell death: the significance of apoptosis.

Authors:  A H Wyllie; J F Kerr; A R Currie
Journal:  Int Rev Cytol       Date:  1980

7.  Sulindac (Clinoril) hepatitis.

Authors:  A K Dhand; D R LaBrecque; J Metzger
Journal:  Gastroenterology       Date:  1981-03       Impact factor: 22.682

8.  Thromboembolism in patients with the 'lupus'-type circulating anticoagulant.

Authors:  M Elias; A Eldor
Journal:  Arch Intern Med       Date:  1984-03

9.  Primary biliary cirrhosis and the CREST syndrome: a report of 22 cases.

Authors:  F C Powell; A L Schroeter; E R Dickson
Journal:  Q J Med       Date:  1987-01

10.  Subclinical liver disease in systemic lupus erythematosus.

Authors:  T Gibson; A R Myers
Journal:  J Rheumatol       Date:  1981 Sep-Oct       Impact factor: 4.666
View more
  48 in total

1.  Polyarteritis nodosa presented as a dilatation of the intrahepatic bile duct.

Authors:  Han Lim Choi; Ro Hyun Sung; Min Ho Kang; Hyun Jeong Jeon; Hyo Yung Yun; Lee Chan Jang; Jae Woon Choi; Young Jin Song; Dong Hee Ryu
Journal:  Ann Surg Treat Res       Date:  2014-10-24       Impact factor: 1.859

Review 2.  Primary biliary cirrhosis in a rheumatoid arthritis patient treated with rituximab, a case-based review.

Authors:  Joaquim Polido-Pereira; Ana Maria Rodrigues; Helena Canhão; Fernando Saraiva; José Alberto Pereira da Silva; João Eurico Fonseca
Journal:  Clin Rheumatol       Date:  2011-10-26       Impact factor: 2.980

3.  A case of dermatomyositis with "liver disease associated with rheumatoid diseases" positive for anti-liver-kidney microsome-1 antibody.

Authors:  Shinji Noda; Yoshihide Asano; Zenshiro Tamaki; Tomonori Takekoshi; Makoto Sugaya; Shinichi Sato
Journal:  Clin Rheumatol       Date:  2010-02-24       Impact factor: 2.980

4.  Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis.

Authors:  C Rigamonti; L M Shand; M Feudjo; C C Bunn; C M Black; C P Denton; A K Burroughs
Journal:  Gut       Date:  2005-09-08       Impact factor: 23.059

5.  Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors.

Authors:  Leonel Daza; Martin Aguirre; Martin Jimenez; Rafael Herrera; J J Bollain
Journal:  Clin Rheumatol       Date:  2006-06-07       Impact factor: 2.980

6.  Chronic myositis with cardiomyopathy and respiratory failure associated with mild form of organ-specific autoimmune diseases.

Authors:  K Tanaka; A Sato; K Kasuga; M Kanazawa; K Yanagawa; M Umeda; M Tada; M Tanaka; M Nishizawa
Journal:  Clin Rheumatol       Date:  2007-08-03       Impact factor: 2.980

7.  Liver cirrhosis in selected autoimmune diseases: a nationwide cohort study in Taiwan.

Authors:  Chien-Hsueh Tung; Ning-Seng Lai; Ming-Chi Lu; Ching-Chih Lee
Journal:  Rheumatol Int       Date:  2015-09-25       Impact factor: 2.631

Review 8.  The development of autoimmune hepatitis and primary biliary cirrhosis overlap syndrome during the course of connective tissue diseases: report of three cases and review of the literature.

Authors:  Cumali Efe; Ersan Ozaslan; Narin Nasiroglu; Hasan Tunca; Tugrul Purnak; Emin Altiparmak
Journal:  Dig Dis Sci       Date:  2009-10-14       Impact factor: 3.199

Review 9.  Drug-induced Liver Injury: The Hepatic Pathologist's Approach.

Authors:  David E Kleiner
Journal:  Gastroenterol Clin North Am       Date:  2017-06       Impact factor: 3.806

Review 10.  Challenge of liver disease in systemic lupus erythematosus: Clues for diagnosis and hints for pathogenesis.

Authors:  Fernando Bessone; Natalia Poles; Marcelo G Roma
Journal:  World J Hepatol       Date:  2014-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.